10-60565907-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001204404.2(ANK3):​c.63+6558C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.47 in 151,914 control chromosomes in the GnomAD database, including 17,165 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 17165 hom., cov: 32)

Consequence

ANK3
NM_001204404.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.299

Publications

6 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.05).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.514 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001204404.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
NM_001204404.2
c.63+6558C>A
intron
N/ANP_001191333.1Q12955-4
ANK3
NM_001204403.2
c.96+49279C>A
intron
N/ANP_001191332.1Q12955-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
ENST00000373827.6
TSL:1
c.96+49279C>A
intron
N/AENSP00000362933.2Q12955-5
ANK3
ENST00000503366.6
TSL:2
c.63+6558C>A
intron
N/AENSP00000425236.1Q12955-4
ANK3
ENST00000510382.1
TSL:2
n.101+49279C>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.470
AC:
71358
AN:
151792
Hom.:
17168
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.391
Gnomad AMI
AF:
0.608
Gnomad AMR
AF:
0.430
Gnomad ASJ
AF:
0.615
Gnomad EAS
AF:
0.451
Gnomad SAS
AF:
0.494
Gnomad FIN
AF:
0.457
Gnomad MID
AF:
0.529
Gnomad NFE
AF:
0.518
Gnomad OTH
AF:
0.505
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.470
AC:
71378
AN:
151914
Hom.:
17165
Cov.:
32
AF XY:
0.469
AC XY:
34791
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.391
AC:
16191
AN:
41414
American (AMR)
AF:
0.429
AC:
6551
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.615
AC:
2134
AN:
3468
East Asian (EAS)
AF:
0.450
AC:
2314
AN:
5144
South Asian (SAS)
AF:
0.496
AC:
2391
AN:
4816
European-Finnish (FIN)
AF:
0.457
AC:
4818
AN:
10552
Middle Eastern (MID)
AF:
0.510
AC:
149
AN:
292
European-Non Finnish (NFE)
AF:
0.518
AC:
35217
AN:
67960
Other (OTH)
AF:
0.504
AC:
1061
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1963
3927
5890
7854
9817
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.480
Hom.:
9936
Bravo
AF:
0.463
Asia WGS
AF:
0.442
AC:
1535
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.1
CADD
Benign
0.31
DANN
Benign
0.21
PhyloP100
-0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10509132; hg19: chr10-62325665; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.